Tropenophthalmologie

In diesem Beitrag zur Tropenophthalmologie geht es uns nicht darum, die spezifischen Tropenkrankheiten im Einzelnen und die 1999 gegründete Initiative VISION 2020 in ihrer gesamten Bandbreite darzustellen. Das ist bereits in diversen Fachzeitschriften ausführlich geschehen und wir möchten den geschätzten Leser auf diese Beiträge verweisen [1]–[4]. Vielmehr geht es uns darum, aufzuzeigen, welche Erfolge insbesondere die Initiative VISION 2020 bereits gezeigt hat, aber auch ihre Schwächen und weitere Herausforderungen sollen herausgearbeitet werden.

• Quellenangaben

• 1 Klauss V, Schaller UC. Tropenophthalmologie–Prävention und Therapie. Ophthalmologe 2004; 101: 741-763
• 2 Klauss V, Schaller UC. Internationale Initiativen zur Prävention von Blindheit. Ophthalmologe 2007; 104: 855-859
• 3 Nentwich MM, Schaller UC, Klauss V. Update: Diagnostik und Therapie von Tropenerkrankungen – Teil 1. Klin Monatsbl Augenheilkd 2009; 226: R139-151
• 4 Nentwich MM, Schaller UC, Klauss V. Update: Diagnostik und Therapie von Tropenerkrankungen – Teil 2. Klin Monatsbl Augenheilkd 2009; 226: R155-169
• 5 Investing in vision: Comparing the costs and benefits of eliminating avoidable blindness and visual impairment. Final report 2013. Im Internet: http://www.hollows.org Stand: Juni 2015
• 6 Palmer JJ, Chinanayi F, Gilbert A et al. Trends and implications for achieving VISION 2020 human resources for eye health targets in 16 countries of sub-Saharan Africa by the year 2020. Hum Resour Health 2014; 12: 45
• 7 Kasper J, Bajunirwe F. Brain drain in sub-Saharan Africa: contributing factors, potential remedies and the role of academic medical centres. Arch Dis Child 2012; 97: 973-979
• 8 Foster A. Cataract and “Vision 2020 – the right to sight” initiative. Br J Ophthalmol 2001; 85: 635-637
• 9 Smith TS, Frick KD, Holden BA. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull World Health Organ 2009; 87: 431-437
• 10 Naidoo KS, Jaggernath J. Uncorrected refractive errors. Indian J Ophthalmol 2012; 60: 432-437
• 11 Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-267
• 12 Thomas R, Naveen S, Nirmalan PK et al. Detection of ocular disease by a vision center technician & the role of frequency doubling technology perimetry in this setting. Br J Ophthalmol 2010; 94: 214-218
• 13 Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14
• 14 Chandna A, Gilbert C. When your eye patient is a child. Community Eye Health 2010; 23: 1-3
• 15 Sudfeld CR, Navar AM, Halsey NA. Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol 2010; 39 (Suppl. 01) i48-i55
• 16 Medsinge A, Nischal KK. Pediatric cataract: challenges and future directions. Clin Ophthalmol 2015; 9: 77-90
• 17 Schulze Schwering M, Finger RP, Barrows J et al. Barriers to uptake of free pediatric cataract surgery in Malawi. Ophthalmic Epidemiol 2014; 21: 138-143
• 18 Gilbert C, Foster A. Childhood blindness in the context of VISION 2020 – the right to sight. Bull World Health Organ 2001; 79: 227-232
• 19 Blencowe H, Lawn JE, Vazquez T et al. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 2013; 74 (Suppl. 01) 35-49
• 20 Burton MJ, Pithuwa J, Okello E et al. Microbial keratitis in East Africa: why are the outcomes so poor?. Ophthalmic Epidemiol 2011; 18: 158-163
• 21 Mbcluskey PJ. Overview of HIV infection and pre-AIDS ocular manifestations. In: Lightman S, ed. HIV and the Eye. London: Imperial College Press; 2000
• 22 Pathai S, Gilbert C, Weiss HA et al. Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa. Trop Med Int Health 2011; 16: 356-359
• 23 Spitzer MS, Batumba NH, Chirambo T et al. Ocular surface squamous neoplasia as the first apparent manifestation of HIV infection in Malawi. Clin Experiment Ophthalmol 2008; 36: 422-425
• 24 Nutt RJ, Clements JL, Dean WH. Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola. Clin Ophthalmol 2014; 8: 2435-2440

• Zum Weiterlesen und Vertiefen

• 25 Schulze Schwering M. Global blindness. Ophthalmologe 2007; 104: 845-848
• 26 Resnikoff S, Pascolini D, Mariottia SP et al. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 2008; 86: 63-70
• 27 Ackland P. The accomplishments of the global initiative VISION 2020: The Right to Sight and the focus for the next 8 years of the campaign. Indian J Ophthalmol 2012; 60: 380-386
• 28 Schulze Schwering M, Spitzer MS, Kalua K et al. Training ophthalmologists for developing economies: an African-German partnership. Postgrad Med J 2014; 90: 61-62
• 29 IAPB. Global action plan 2014. Im Internet: http://www.iapb.org/advocacy/who-action-plan Stand: Juni 2015
• 30 Rao GN. The Barrie Jones Lecture-Eye care for the neglected population: challenges and solutions. Eye (Lond) 2015; 29: 30-45

Weitere Literatur beim Verfasser